• World Veterinary Vaccine Congress 2018

    Science, new technology and strategy for the veterinary vaccine sector

    29-31 October 2019, Palau de Congressos de Catalunya, Barcelona

     

  • World Veterinary Vaccine Congress 2018

    Science, Strategy and Partnerships for the Veterinary Vaccine Sector

    29-31 October 2019, Palau de Congressos de Catalunya, Barcelona

     

New veterinary vaccine technology is
changing the whole industry

 

Now in its 4th year the World Veterinary Vaccine Congress will continue to bring experts from the whole value chain under one roof, where you get to meet decision makers in the areas that are most applicable for your business offering.

A three day event, co-located with the 19th World Vaccine Congress Europe, where the global animal health industry meets to discuss scientific, regulatory and commercial issues from new innovative vaccine technologies to emerging disease.

Focused on R&D innovations, we will update you of the progression made in veterinary vaccine R&D and vaccine development challenges when developing vaccines against viral, bacterial and parasitic diseases within a variety of animal species.

From modified live virus vaccines, DNA vaccines, subunit marker vaccines to novel adjuvanted vaccines, this congress brings all innovation together in one place.

 

THE WORLD VETERINARY VACCINE CONGRESS EUROPE WILL:

  • Provide a marketplace where the world’s leading veterinary vaccine focused CROs, CMOs, Equipment, Platform Technology and device manufacturers can showcase their services and products to decision makers.
  • Provide delegates one stop progressive scientific and strategic solutions to the veterinary vaccine industry, through executive level commentary, case studies and real time analysis from key stakeholders to bring about faster, more cost-effective and more efficacious vaccines.
  • Create a valuable marketplace for pharma and biotech involved in veterinary vaccines to source and compare products and services that will help them.
  • Explore the latest methods for improving bioprocessing and manufacturing methodologies for current and future veterinary vaccines and look into new technologies for vaccine development, including nanotech, synthetic biology and new-generation adjuvants
  • Offer delegates updates on the latest discovery-stage prophylactic and therapeutic vaccines and hear clinical phase I, II and III data from leading biotech’s and big pharma.
  • Showcase C-Level executives from all the key vaccine developers and thought leaders from pharma, biotech’s, academics and government, in a combined scientific and commercial environment where CRO’s, CMO’s, Equipment, Platform Technology and device manufacturers can do business.

 

 

CO-LOCATED WITH:

 

 

 

 

Scientific Advisory Board

 

Professor Albert Osterhaus Professor Albert Osterhaus
Director, Research Center for Emerging Infections and Zoonoses (RIZ) 
University of Veterinary Medicine Hannover

Dr Jeffrey Almond Dr Jeffrey Almond
Former Vice President Discovery Research and Development, Sanofi and Visiting Professor  
University of Oxford - Oxford Vaccine Group

Dr Jan Poolman Dr Jan Poolman
Head Bacterial Vaccine Discovery and Early Development  
Janssen

Dr Gregory A. Poland Dr Gregory A. Poland 
Director of Mayo Vaccine Research Group  
Mayo Clinic and Foundation

Dr Antu Dey Dr Antu Dey
Senior Director, Research & Development  
International AIDS Vaccine Initiative

Konrad Stradler Dr Konrad Stradler
Head of R&D Vaccines  
Boehringer Ingelheim

Dr Roy Baynes Dr Roy Baynes
Senior Vice President Global Clinical Development and Chief Medical Officer  
MSD

Dr Nathalie Garçon Dr Nathalie Garçon 
CEO & CSO  
BIOASTER

Dr Cyril Gay   Dr Cyril Gay
Senior National Program Leader, Office of National Programs  
USDA

Dr Rino Rappuoli  Dr Rino Rappuoli
Chief Scientist  
GSK Vaccines

Dr Mahesh Kumar Dr Mahesh Kumar
Vice President, Global Biologics Research  
Zoetis

Dr Bernard Vallat Dr Bernard Vallat
Honorary Director General  
Office International Des Epizooties

Dr Ralf Clemens Dr Ralf Clemens
SVP
GRID Rio

Dr Jerald Sadoff Dr Jerald Sadoff 
Senior Advisor  
Janssen Infectious Diseases and Vaccines

Dr Lorne A. Babiuk Dr Lorne A. Babiuk
Former Vice-President
University of Alberta

Prof Roman Prymula Prof Roman Prymula
Professor Preventive Medicine
Charles University in Prague

Prof Hanna Nohynek Prof Hanna Nohynek 
Deputy Director
Finish Public Health

Prof Fred Zepp Prof Fred Zepp
Medical Director and Chairman of the Department of Paediatrics
University Medicine Mainz

Dr Annaliesa Anderson Dr Annaliesa Anderson
VP Bacterial Vaccines
Pfizer

Dr Joris Vandeputte Dr Joris Vandeputte
President 
IABS (International Alliance for Biological Standardization)

Prof Hanneke Schuitemaker Prof Hanneke Schuitemaker
Global Head of Viral Vaccine Discovery and Translational Medicine in the Infectious Disease and Vaccines Therapeutic Area 
Janssen Vaccines

Dr Miles Carroll Dr Miles Carroll
Deputy Director 
Public Health England

 

 

 
 
 

 

Dr Greg Poland Invites You To Attend

 

 

REGISTER NOW

 

"Great conference, well organized, great opportunity to network with individuals in the vaccine world."


VP Software & Electronics, LumaCyte

 

Put your company at the forefront of the industry and sponsor the World Veterinary Vaccine Congress

Download the prospectus to see how you can get involved

 

DOWNLOAD PROSPECTUS

 

Sign Up for Event Updates